Efficacy and Safety of Angong Niuhuang Wan for Stroke
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT04236427
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 2/3
- Enrolled
- 100 participants
- Registry
-
NCT04236427
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Hong Kong SAR China
- Registry status
- Unknown status
Technical summary
Registry record NCT04236427. Randomized; quadruple masking; primary purpose prevention. Start 2019-10-15 (actual); primary completion 2022-12-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Angong Niuhuang Wan for Stroke
- Condition
- Stroke (CVA) or TIA (transient ischemic attack)
- Intervention (Drug)
- Angong Niuhuang Wan
- Intervention (Drug)
- Angong Niuhuang Wan Placebo
- Lead sponsor
- Chinese University of Hong Kong
Record details
- Record id
cardio:ct-nct04236427- Content hash
67fd884b0734d286fcf8e64ff510ffed430255417d171ceedc8d7c33b5051257